These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. A review and assessment of drug-induced parotitis. Brooks KG; Thompson DF Ann Pharmacother; 2012 Dec; 46(12):1688-99. PubMed ID: 23249870 [TBL] [Abstract][Full Text] [Related]
13. Nitrofurantoin-induced parotitis. Meyboom RH; van Gent A; Zinkstok DJ Br Med J (Clin Res Ed); 1982 Oct; 285(6347):1049. PubMed ID: 6812739 [No Abstract] [Full Text] [Related]
14. Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica. Wadman B; Werner I Lancet; 1967 Mar; 1(7490):597-8. PubMed ID: 4163976 [No Abstract] [Full Text] [Related]
15. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Inman WH Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632 [TBL] [Abstract][Full Text] [Related]
16. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidine). Krook G Contact Dermatitis; 1975 Dec; 1(6):385-6. PubMed ID: 139265 [No Abstract] [Full Text] [Related]
17. Oxyphenbutazone (Tanderil) and blood dyscrasia. Brownlie BE; Strang PJ N Z Med J; 1969 Feb; 69(441):77-9. PubMed ID: 5252205 [No Abstract] [Full Text] [Related]